99 related articles for article (PubMed ID: 1731463)
21. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
[TBL] [Abstract][Full Text] [Related]
22. Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
Touyz RM; Schiffrin EL
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1214-21. PubMed ID: 8998256
[TBL] [Abstract][Full Text] [Related]
23. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
Day RW
Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
[TBL] [Abstract][Full Text] [Related]
24. Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.
Andersson OK; Granérus G; Hedner T
Drugs; 1985; 29 Suppl 2():102-8. PubMed ID: 3886356
[TBL] [Abstract][Full Text] [Related]
25. The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.
Zervoudaki A; Economou E; Pitsavos C; Vasiliadou K; Aggeli C; Tsioufis K; Toutouza M; Stefanadis C; Toutouzas P
Am J Hypertens; 2004 Mar; 17(3):273-6. PubMed ID: 15001203
[TBL] [Abstract][Full Text] [Related]
26. Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin.
Marone C; Beretta-Piccoli C; Weidmann P
Kidney Int; 1981 Jul; 20(1):92-6. PubMed ID: 7029119
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide.
Inouye IK; Massie BM; Benowitz N; Simpson P; Loge D
Am J Cardiol; 1984 Jun; 53(11):1588-92. PubMed ID: 6375339
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension.
Grossman E; Peleg E; Carroll J; Shamiss A; Rosenthal T
Am J Hypertens; 1994 Dec; 7(12):1041-4. PubMed ID: 7702796
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
Young TE; Lundquist LJ; Chesler E; Weir EK
Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
[TBL] [Abstract][Full Text] [Related]
31. [Calcium channel blocking agents and albuminuria in diabetic and hypertensive patients. A pilot study].
Lamarre-Cliche M; Lambert R; Van Nguyen P; Cusson J; Wistaff R; Larochelle P
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):919-24. PubMed ID: 10989730
[TBL] [Abstract][Full Text] [Related]
32. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure.
Grossman E; Messerli FH
Am J Cardiol; 1997 Dec; 80(11):1453-8. PubMed ID: 9399721
[TBL] [Abstract][Full Text] [Related]
33. [Hypotensive effect and characteristics of the effect on the central hemodynamics of the delayed-action form of diltiazem (Dilren) in patients with hypertension].
Pshenitsin AI; Glotov MN; Mazur NA
Ter Arkh; 1993; 65(9):47-50. PubMed ID: 8303596
[TBL] [Abstract][Full Text] [Related]
34. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
Lucarini AR; Salvetti A
Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
[TBL] [Abstract][Full Text] [Related]
35. Reversal of target-organ involvement in systemic hypertension: a pharmacologic experience.
Frohlich ED
Am J Cardiol; 1987 Dec; 60(17):3I-7I. PubMed ID: 2961248
[TBL] [Abstract][Full Text] [Related]
36. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
[TBL] [Abstract][Full Text] [Related]
37. Candesartan cilexetil and renal hemodynamics in hypertensive patients.
Fridman K; Wysocki M; Friberg P; Andersson OK
Am J Hypertens; 2000 Sep; 13(9):1045-8. PubMed ID: 10981559
[TBL] [Abstract][Full Text] [Related]
38. Immediate hemodynamic effects of urapidil in patients with essential hypertension.
Kobrin I; Amodeo C; Ventura HO; Messerli FH; Frohlich ED
Am J Cardiol; 1985 Mar; 55(6):722-5. PubMed ID: 3976516
[TBL] [Abstract][Full Text] [Related]
39. Vasodilators, antihypertensive therapy and the kidney.
Hollenberg NK
Am J Cardiol; 1987 Dec; 60(17):57I-60I. PubMed ID: 3687806
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic comparison of diltiazem and TA-3090 in spontaneously hypertensive and normal Wistar-Kyoto rats.
Isshiki T; Pegram BL; Frohlich ED
Am J Cardiol; 1988 Oct; 62(11):79G-84G. PubMed ID: 3177230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
